Research News for September 2012
-
Regular Screening Helps Reduce Difference in Breast Cancer Outcomes Between African American and White Women
A study suggests that regular screening mammograms can help improve the outcomes of African American women diagnosed with breast cancer.
-
MRI Before Surgery Doesn’t Reduce Need for More Surgery Later On
A study suggests that having an MRI before initial breast cancer surgery doesn’t reduce the likelihood that a woman would need more breast cancer surgery later.
-
New Screening Device for Dense Breasts Approved by FDA
The FDA has approved an automated ultrasound device to screen for breast cancer in women with dense breasts.
-
Study Analyzes Breast Cancer Genetics, Finds Four Classes of Disease
Researchers have done the most thorough analysis of breast cancer genetics to date and found that there are four genetically distinct classes of the disease.
-
Mammograms Save Lives, Benefits Outweigh Concerns
A European study has found that for every 1,000 women between the ages of 50 and 70 who get a mammogram every 2 years, seven to nine lives are saved.
-
Use of Anthracyclines to Treat Breast Cancer Has Gone Down
A study has found that after 2005, there was a large increase in taxane chemotherapy and a decrease in anthracycline chemotherapy to treat breast cancer in the United States.
-
Radiation in Diagnostic Tests Increases Risk for Women with Abnormal BRCA1 or BRCA2 Genes
A new study suggests that diagnostic tests that use radiation done before age 30 in young women with an abnormal BRCA1 or BRCA2 gene increases breast cancer risk.
-
Genetic Counseling Before Surgery Can Lower Stress and Help Women Make Decisions
A small study has found that women diagnosed with breast cancer who are offered genetic counseling before breast cancer surgery have less stress and make more informed decisions about treatment compared to women who don’t get genetic counseling before surgery.
-
Combination of Arimidex and Faslodex Better Than Arimidex Alone to Treat Metastatic Breast Cancer
A study has found that postmenopausal women diagnosed with hormone-receptor-positive metastatic breast cancer and treated with a combination of Arimidex and Faslodex as the first treatment for metastatic disease lived about 6 months longer than women treated only with Arimidex.
-
Lying Face Down for Radiation Therapy to Treat Breast Cancer May Protect Healthy Tissue
A study suggests that lying face down to receive radiation therapy to the breast area reduces the amount of radiation that unintentionally reaches the heart and lungs.
